AVIVA's technology and expertise in ion channel drug screening is available to the pharmaceutical and biotech industries, offering a variety of high quality drug discovery resources.
AVIVA provides its clients with the full support of its bank of automated electrophysiology instruments, highly qualified and experienced personnel and reliable and timely customer service. Conventional electrophysiology assays are also available upon request.
AVIVA has developed a set of tools and protocols that allow the ultra-rapid generation of new custom cell lines. Up to 3 different polypeptides can be co-expressed in each cell line. This revolutionary approach allows us to provide our customers with new cell lines in as little as three weeks.
AVIVA can evaluate cardiac and vascular safety of experimental compounds using in vitro human tissue assays. These studies eliminate all concerns about cross species pharmacological differences and represent an efficient and cost effective approach to first-in-human safety.